MENU
TENX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tenax Therapeutics (TENX) Ownership - Who owns Tenax Therapeutics?
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
101 Glen Lennox Drive
Phone
+1 919 855-2100
Employees
6
Web
https://www.tenaxthera.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
24.98M
P/E Ratio
N/A
Total Cash
98.31M
Projected Growth
N/A
Total Debt
278.8K
Revenue
N/A
Risk (Beta)
1.79
Dividend Yield
N/A
Total Cash/Share
24.79
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TENX
Capitalization
25M
P/E Ratio
N/A
Risk (Beta)
1.79
Dividend Yield
N/A
Total Cash
98.3M
Total Cash/Share
24.79
Total Debt
279K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
97.2M
P/B Ratio
0.27
Cash Flow
N/A
Earnings
-13.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
341
Current Ratio
38.95
Current Revenue Per Employee
4107.17
Dividends Per Share - Security
N/A
EBITDA
-14.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-26.08
Shares Held By Institutions
8.73M
Shares Outstanding - Current
3.97M
Total Liabilities
2.56M
Total Volume MTD
N/A
Value
1
Gain YTD
2.746
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel therapeutic products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
101 Glen Lennox Drive
Phone
+1 919 855-2100
Employees
6
Web
https://www.tenaxthera.com